Olaparib
-
Zydus launches IBYRA for cancer care
The drug will target specific genetic mutations prevalent in certain types of cancers Zydus has launched Olaparib, a PARP inhibitor,…
Read More »
The drug will target specific genetic mutations prevalent in certain types of cancers Zydus has launched Olaparib, a PARP inhibitor,…
Read More »